Education
About Us
Working with TipRanks
Follow Us
Vikas Sinha Insider Profile
60 Followers
Vikas Sinha, EVP & CFO at Alexion Pharmaceuticals, holds 74.44K shares in Verona Pharma (Ticker: VRNA), holds 600.00K shares in Scholar Rock Holding (Ticker: SRRK), holds 774.12K shares in Kalaris Therapeutics (Ticker: KLRS).
Profitable Transactions
37 out of 41 Profitable Transactions
Average Return
+45.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Vikas Sinha holds in companies
Most Profitable Insider Trade
The most profitable trade made by Vikas Sinha
Vikas Sinha's Trading History
Alexion Pharmaceuticals
Aug 10, 2016
―
Informative Sell
37.99K
$31.36M
Kalaris Therapeutics
Feb 24, 2025
President, CFO and CEO, Director, Ten Percent Owner
Informative Sell
3.05K
$2.26M
Verona Pharma
May 22, 2025
Director
Uninformative Buy
80.00K
$7.82M
Scholar Rock Holding
Apr 29, 2025
CFO
Uninformative Buy
―
$22.25M
List of latest transactions for each holding click on a transaction to see Vikas Sinha's performance on stock
You May Also Like
Vikas Sinha insider profile FAQ
What is the percentage of profitable transactions made by Vikas Sinha?
The percentage of profitable transactions made by Vikas Sinha is 90%.
What is the average return per transaction made by Vikas Sinha?
The average return per transaction made by Vikas Sinha is 45.90%.
What stocks does Vikas Sinha hold?
Vikas Sinha holds: ALXN, KLRS, VRNA, SRRK stocks.
What was Vikas Sinha’s latest transaction?
Vikas Sinha latest transaction was an Uninformative Buy of $80.00K.
What was Vikas Sinha's most profitable transaction?
Vikas Sinha’s most profitable transaction was an Informative Sell of KLRS stock on November 6, 2024. The return on the trade was 88.10%.
What is Vikas Sinha's role in Alexion Pharmaceuticals?
Vikas Sinha's role in Alexion Pharmaceuticals is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.